Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Elena Babak
Observed name:
E Babak
Institution:
AstraZeneca (Canada)
Observed institutions:
University of Alberta,
AstraZeneca (Canada)
OpenAlex ID:
A5001803913
International consensus definitions of clinical trial outcomes for kidney failure: 2020
2020
·
Adeera Levin
, Rajiv Agarwal
, et al.
·
Kidney International
·
133
PDF
Changing paradigms of studies in kidney diseases
2025
·
Adeera Levin
, Allison Jaure
, et al.
·
Kidney International
·
8
PDF
Abstract WP231: The Incidence of Intracranial Hemorrhage in Patients Anticoagulated With Factor Xa Inhibitors (FXai): A Multi-Country Observational Study (AXIOM ICH)
2024
·
Alexander T Cohen
, Robert C Welsh
, et al.
·
Stroke
·
1
Factor Xa inhibitor associated major bleeding characteristics, burden, and health resource utilization in Alberta, Canada - an observational population based study
2025
·
R Welsh
, C R Jarvis
, et al.
·
European Heart Journal
B.4 Time to intervention in anticoagulant-associated intracerebral hemorrhage: gaps in care and their effect on hematoma expansion
2025
·
C Brassard
, C Dumouchel
, et al.
·
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
PDF
Abstract DP49: Time Metrics in Acute Management of Anticoagulant-Associated Acute Intracerebral Hemorrhage: The Need for Speed
2025
·
Catherine Brassard
, Charles Dumouchel
, et al.
·
Stroke
Factor Xa Inhibitor-associated Major Bleeding Characterization Burden and Management in Alberta Canada - a Retrospective Observational Population-based Study
2024
·
Andrea Shysh
, Robert C. Welsh
, et al.
·
Journal of the American College of Cardiology
Show more works
View as search
Works count:
7
Citation count:
142
H-index:
2
I10-index:
1
Year
Topic
Type